Publication | Closed Access

Global Registration Trial of Efficacy and Safety of CTL019 in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Update to the Interim Analysis

Hematological MalignancyInterim AnalysisMedicineMixed-phenotype Acute LeukemiaAcute Lymphoblastic LeukemiaClinical TrialsGlobal Registration TrialAdult T-cell Leukemia-lymphomaOncologyRadiation OncologyHealth Sciences